ArticleFrontiers in immunology2026

Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1.

Ines Zettl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.